Anti-inflammatory natural product goniothalamin reduces colitis-associated and sporadic colorectal tumorigenesis

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Carcinogenesis

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/carcin/bgw112PMID 27797827PMCID PMC5219049
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Goniothalamin prevents the development of chemically induced and spontaneous colitis in rodents and induces apoptosis in the HT-29 human colon tumor cell line.

  2016cited by this paper
• Anti-inflammatory therapies in TRAMP mice: delay in PCa progression.

  2016cited by this paper
• Aspirin and Colorectal Cancer Prevention and Treatment: Is It for Everyone?

  2016cited by this paper
• Anti-inflammatory and antinociceptive effects of racemic goniothalamin, a styryl lactone.

  2015cited by this paper
• Cytokines, IBD, and Colitis-associated Cancer

  2015cited by this paper
• Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

  2015cited by this paper
• Chitinase 3-like 1 induces survival and proliferation of intestinal epithelial cells during chronic inflammation and colitis-associated cancer by regulating S100A9

  2015cited by this paper
• Cancer statistics, 2015

  2015cited by this paper
• Spontaneous Intestinal Tumorigenesis in Apc /Min+ Mice Requires Altered T Cell Development with IL-17A

  2015cited by this paper
• The multifaceted role of the intestinal microbiota in colon cancer.

  2014cited by this paper
• Cytokines in inflammatory bowel disease

  2014influential reference
• Design and Synthesis of N‐Acylated Aza‐Goniothalamin Derivatives and Evaluation of Their in vitro and in vivo Antitumor Activity

  2014cited by this paper
• Microbiome, Inflammation, and Cancer

  2014cited by this paper
• Emerging Anticancer Potentials of Goniothalamin and Its Molecular Mechanisms

  2014cited by this paper
• Alarmin S100A8/S100A9 as a biomarker for molecular imaging of local inflammatory activity

  2014cited by this paper
• Synthetic triterpenoid induces 15-PGDH expression and suppresses inflammation-driven colon carcinogenesis.

  2014cited by this paper
• A new goniothalamin N-acylated aza-derivative strongly downregulates mediators of signaling transduction associated with pancreatic cancer aggressiveness.

  2014cited by this paper
• Neutrophil infiltration favors colitis-associated tumorigenesis by activating the interleukin-1 (IL-1)/IL-6 axis

  2014influential reference
• Gastroprotective effects of goniothalamin against ethanol and indomethacin-induced gastric lesions in rats: Role of prostaglandins, nitric oxide and sulfhydryl compounds.

  2014cited by this paper
• Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis.

  2014cited by this paper
• Chemoprotection against cancer by isothiocyanates: a focus on the animal models and the protective mechanisms.

  2013cited by this paper
• Sox9 induction, ectopic Paneth cells, and mitotic spindle axis defects in mouse colon adenomatous epithelium arising from conditional biallelic Apc inactivation.

  2013influential reference
• Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model

  2013cited by this paper
• Natural products: a continuing source of novel drug leads.

  2013cited by this paper
• Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth

  2012cited by this paper
• Implications of anti-cytokine therapy in colorectal cancer and autoimmune diseases

  2012cited by this paper
• IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine

  2012cited by this paper
• Molecular link mechanisms between inflammation and cancer.

  2012cited by this paper
• IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation

  2012cited by this paper
• Inflammation and colorectal cancer: colitis-associated neoplasia

  2012cited by this paper
• The increased expression of IL‐23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Opposing consequences of IL-23 signaling mediated by innate and adaptive cells in chemically induced colitis in mice

  2011cited by this paper
• Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.

  2011cited by this paper
• S100A8/A9 Activate Key Genes and Pathways in Colon Tumor Progression

  2011cited by this paper
• Non-Steroidal Anti-Inflammatory Drugs and Colorectal Cancer Risk in a Large, Prospective Cohort

  2011cited by this paper
• Effect of goniothalamin on the development of Ehrlich solid tumor in mice.

  2010cited by this paper
• Eicosanoids and cancer

  2010cited by this paper
• Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis

  2010cited by this paper
• Immunity, inflammation, and cancer.

  2010cited by this paper
• The endogenous Toll–like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer

  2009cited by this paper
• IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

  2009cited by this paper
• Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens

  2009cited by this paper
• NF-kappaB as a critical link between inflammation and cancer.

  2009cited by this paper
• Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis.

  2008cited by this paper
• RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis

  2008influential reference
• Systematic review of the association between circulating interleukin-6 (IL-6) and cancer.

  2008cited by this paper
• Increased susceptibility to colitis-associated cancer of mice lacking TIR8, an inhibitory member of the interleukin-1 receptor family.

  2007influential reference
• Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation.

  2007cited by this paper
• Gnotobiotic IL-10-/-;NF-kappa B(EGFP) mice reveal the critical role of TLR/NF-kappa B signaling in commensal bacteria-induced colitis.

  2007cited by this paper
• Gnotobiotic IL-10−/−;NF-κBEGFP Mice Reveal the Critical Role of TLR/NF-κB Signaling in Commensal Bacteria-Induced Colitis1

  2007cited by this paper
• NF-kappaB: linking inflammation and immunity to cancer development and progression.

  2005cited by this paper
• (R)-Goniothalamin: total syntheses and cytotoxic activity against cancer cell lines.

  2005cited by this paper
• TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.

  2004influential reference
• TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling

  2004cited by this paper
• The IKK/NF-κB activation pathway—a target for prevention and treatment of cancer

  2004cited by this paper
• The IKK/NF-kappaB activation pathway-a target for prevention and treatment of cancer.

  2004influential reference
• Synthesis and biological evaluation of cytostatin analogues.

  2003cited by this paper
• A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.

  2003cited by this paper
• Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups

  2001cited by this paper
• A simplified method of evaluating dose-effect experiments.

  1948cited by this paper
• A simplified method of evaluating dose-effect experiments.

  1948cited by this paper

• Explore the key targets and mechanism of Danggui Buxue decoction against ulcerative colitis: network pharmacology and experimental validation.

  2025cites this paper
• Screening of targets related to amino acid metabolism in glioma to identify the tumor-promoting effects of its core gene ASL

  2025cites this paper
• Goniothalamus macrophyllus: A Comprehensive Review of Its Phytochemistry, Pharmacological Activities, and Therapeutic Potential

  2025cites this paper
• The Roles of Dietary Bioactive Compounds in Alleviating Inflammatory Bowel Disease‐Associated Colorectal Cancer

  2025cites this paper
• A comprehensive review of phytochemicals targeting macrophages for the regulation of colorectal cancer progression.

  2024cites this paper
• Pyroptosis in cancer treatment and prevention: the role of natural products and their bioactive compounds

  2024cites this paper
• Research progress on anti-inflammatory drugs for preventing colitis-associated colorectal cancer.

  2024cites this paper
• Anti-proliferation effect of chitooligosaccharide on colitis-associated cancer in mice: Possible involvement of miRNA-155/TLR4/Reg3g pathway

  2024cites this paper
• Chemopreventive potential of goniothalamin in diethylnitrosamine-induced hepatocellular carcinoma through the suppression of P13K/AKT signalling pathway

  2024cites this paper
• Natural products with anti-tumorigenesis potential targeting macrophage.

  2024cites this paper
• Dichloromethane stem bark extract of Goniothalamus lanceolatus Miq. modulates inflammatory cytokines and ameliorates tissue damage in Plasmodium berghei-infected mice

  2022cites this paper
• Meta-substituted piperlongumine derivatives attenuate inflammation in both RAW264.7 macrophages and a mouse model of colitis.

  2021cites this paper
• Vitexin prevents colitis-associated carcinogenesis in mice through regulating macrophage polarization.

  2021cites this paper
• Hybrids of 4-hydroxy derivatives of goniothalamin and piplartine bearing a diester or a 1,2,3-triazole linker as antiproliferative agents.

  2021cites this paper
• Selinexor for advanced hematologic malignancies

  2020cites this paper
• Goniothalamin-Related Styryl Lactones. Isolation, Synthesis, Biological Activity and Mode of Action.

  2020cites this paper
• Inhibitors of nuclear transport.

  2019cites this paper
• Pristimerin suppresses colorectal cancer through inhibiting inflammatory responses and Wnt/β-catenin signaling.

  2019cites this paper
• IL‐17 and colorectal cancer: From carcinogenesis to treatment

  2019cites this paper
• Dendrobium officinale polysaccharides alleviate colon tumorigenesis via restoring intestinal barrier function and enhancing anti-tumor immune response.

  2019cites this paper
• Human disorders associated with inflammation and the evolving role of natural products to overcome.

  2019cites this paper
• Synthesis of Nitrogen‐Containing Goniothalamin Analogues with Higher Cytotoxic Activity and Selectivity against Cancer Cells

  2019cites this paper
• Histological, Biochemical, and Hematological Effects of Goniothalamin on Selective Internal Organs of Male Sprague-Dawley Rats

  2019cites this paper
• Steroidal hormone and morphological responses in the prostate anterior lobe in different cancer grades after Celecoxib and Goniothalamin treatments in TRAMP mice

  2018cites this paper
• Metformin inhibited colitis and colitis-associated cancer (CAC) through protecting mitochondrial structures of colorectal epithelial cells in mice

  2018cites this paper
• Selective inhibition of P-gp transporter by goniothalamin derivatives sensitizes resistant cancer cells to chemotherapy

  2018cites this paper
• Annonaceae: Breaking the Wall of Inflammation

  2017cites this paper
• Serum IL-6, IL-23 profile and Treg/Th17 peripheral cell populations in pediatric patients with inflammatory bowel disease.

  2017cites this paper
• Goniothalamin and Celecoxib Effects During Aging: Targeting Pro‐Inflammatory Mediators in Chemoprevention of Prostatic Disorders

  2017cites this paper
• Aberrant control of NF-κB in cancer permits transcriptional and phenotypic plasticity, to curtail dependence on host tissue: molecular mode

  2017cites this paper